Condition
Inflammation; Skin
Total Trials
7
Recruiting
0
Active
0
Completed
6
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
0%
0 of 6 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
7Total
Not Applicable (4)
Early P 1 (1)
P 1 (1)
P 4 (1)
Trial Status
Completed6
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT04848194Not ApplicableCompletedPrimary
Pleiotropic Role of TRPV1 in Psoriasis Inflammation
NCT05110313Phase 4Completed
Effects of Tildrakizumab on Epigenetic Age
NCT05913791Not ApplicableUnknown
Nutrients-fortified Egg Consumption on Eczema Condition in Individuals With Eczema
NCT03183830Phase 1Completed
Influence of Dietary Nitrate on Skin Inflammation
NCT04308889Early Phase 1CompletedPrimary
Pro-Resolving Mediators in Acute Inflammation in Humans
NCT03779360Not ApplicableCompletedPrimary
Intradermal LPS and Antibiotics
NCT03066791Not ApplicableCompletedPrimary
Turmeric and Curcumin on Sebum Production
Showing all 7 trials